AC
Armistice Capital, LLC disclosed a 9.9% stake in KYNB
Armistice Capital, LLC reported owning 9.9% of Kyntra Bio, Inc. (KYNB) (400,000 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.